• PKM2 Inhibitor (Compound 3k): Selective Disruption of Tumor

  2026-04-20

  PKM2 inhibitor (compound 3k) is a potent small molecule that selectively inhibits pyruvate kinase M2, disrupting glycolytic metabolism in tumor cells. This targeted approach induces autophagic cell death and demonstrates high antiproliferative efficacy in preclinical cancer models. Compound 3k represents a promising research and therapeutic tool for PKM2-overexpressing cancers.

• QPRT Drives Breast Cancer Invasion via PLC-Dependent Myosin

  2026-04-19

  Liu et al. (2021) elucidate how quinolinate phosphoribosyltransferase (QPRT) enhances breast cancer cell invasiveness by promoting myosin light chain phosphorylation through PLC signaling. Their findings identify QPRT as a potential prognostic marker and therapeutic target, with implications for modulating metastatic behavior via pathway-specific inhibitors.

• Gallein as a G Protein βγ Inhibitor: From Mechanism to Model

  2026-04-18

  Explore how Gallein, a premier G protein βγ subunit inhibitor, enables precise modulation of GPCR signaling in cancer and autoimmune disease models. This article uniquely bridges molecular mechanism with advanced assay and model choice.

• Cell Counting Kit-8 Plus: Sensitive Tetrazolium Salt Assay W

  2026-04-17

  Cell Counting Kit-8 (CCK-8) Plus sets a new standard for rapid and reproducible cell proliferation and cytotoxicity assays, leveraging enhanced WST-8 chemistry for superior sensitivity. Discover how this kit empowers high-throughput drug screening and inflammation studies, with actionable protocol optimizations and troubleshooting strategies.

• SB743921: Optimizing Kinesin Spindle Protein Inhibitor Workf

  2026-04-16

  SB743921 elevates cancer research by precisely targeting mitotic kinesin, driving robust cell cycle arrest and apoptosis in preclinical models. Discover protocol refinements, troubleshooting strategies, and advanced applications that maximize its translational impact.

• Foretinib (GSK1363089): Precision Multikinase Inhibition Wor

  2026-04-15

  Foretinib (GSK1363089) stands out as a potent, nanomolar ATP-competitive tyrosine kinase inhibitor for dissecting tumor proliferation, migration, and metastasis in preclinical models. This article provides practical, evidence-driven guidance for integrating Foretinib into advanced cancer research workflows, drawing on robust in vitro methods, protocol optimization, and troubleshooting strategies.

• A23187, Free Acid: Precision Calcium Ionophore for Applied R

  2026-04-14

  A23187, free acid offers benchmark control over intracellular calcium, enabling robust, quantifiable studies of apoptosis, contractility, and phosphoinositide signaling. This guide delivers actionable protocols, troubleshooting insights, and experimental enhancements for maximizing reproducibility and discovery in complex cell models.

• Lipidomic Shifts in Persister Cancer Cells Enhance Ferroptos

  2026-04-13

  This study reveals that drug-tolerant persister cancer cells exhibit distinct, reversible lipidomic alterations that heighten their vulnerability to ferroptosis. The findings highlight mitochondrial involvement in shaping lipid profiles and ferroptosis sensitivity, offering new directions for targeting minimal residual disease and drug-resistant cancer populations.

• Triple Therapy Enhances Abscopal Effects via CD8+ T Cells

  2026-04-12

  This study demonstrates that combining radiotherapy with PD-1 and TIGIT blockade induces robust antitumor abscopal effects and long-term immune memory mediated by CD8+ T cells. The findings clarify mechanisms of immune resistance and offer a translational strategy to improve clinical outcomes in cancer immunotherapy.

• Trametinib (GSK1120212): Advancing Translational Oncology Pr

  2026-04-12

  This thought-leadership article explores the mechanistic precision and strategic applications of Trametinib (GSK1120212) in translational oncology. Building on recent discoveries around tumor heterogeneity and metastasis, it offers actionable guidance for researchers seeking to optimize MEK-ERK pathway inhibition, maximize experimental reproducibility, and anticipate therapeutic challenges in B-RAF mutated and colorectal cancer models. Evidence from recent literature, including Cho et al. (2019), is integrated with best practices and novel perspectives beyond standard product descriptions.

• Sulfaphenazole: Applied Strategies for CYP2C9 Inhibitor Rese

  2026-04-11

  Sulfaphenazole excels as a selective CYP2C9 inhibitor, streamlining drug metabolism studies and vascular function research with reproducible, low-cytotoxicity performance. Its dual action—modulating oxidative stress and exerting antibacterial effects—enables uniquely cross-domain experimental designs. This guide covers practical workflows, troubleshooting, and the latest in tissue repair applications.

• AT-406 (SM-406): Applied Workflows for Cancer Apoptosis Rese

  2026-04-11

  AT-406 (SM-406) uniquely empowers researchers to unravel and manipulate apoptosis pathways in cancer models, providing precise, reproducible induction and quantification of cell death. This guide translates recent structural breakthroughs and validated protocols into actionable steps, troubleshooting insights, and comparative advantages for both in vitro and in vivo oncology workflows.

• Translational Synergy: Leveraging BMS-777607 for Advanced...

  2026-04-10

  Explore the strategic and mechanistic dimensions of BMS-777607, a selective and potent ATP-competitive MET kinase inhibitor, in the context of cancer metastasis models and stem cell differentiation. This thought-leadership article bridges foundational biological rationale, experimental evidence, and translational opportunities, while providing actionable guidance for researchers seeking to elevate their preclinical workflows using APExBIO’s BMS-777607.

• Safe DNA Gel Stain: Advanced Strategies for DNA Integrity...

  2026-04-09

  Explore how Safe DNA Gel Stain enhances nucleic acid visualization with blue-light excitation, minimizes DNA damage, and uniquely improves molecular cloning workflows. This article provides advanced scientific insights and practical strategies for safer, high-fidelity nucleic acid detection in modern molecular biology.

• Baicalin in Translational Research: Pathway Modulation an...

  2026-04-08

  Explore how Baicalin, a flavone glycoside from Scutellaria baicalensis, drives translational breakthroughs via precise KEAP1-NRF2/HO-1 and TGF-β1/p-Smad3 pathway modulation. This article uniquely integrates mechanistic depth with advanced applications in both cancer and neuroplasticity research.

406 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page